Management of young onset colorectal cancer: Divergent practice in the East of England

Colorectal Disease

Volumn 13, Issue 9, 2011, Pages

  Anning, L ^a   Koo, N ^a   Neely, J ^a   Wells, A ^b   Clark, S K ^c   Miller, R ^a   Will, Olivia ^b  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b HINCHINGBROOKE HOSPITAL   (United Kingdom)

^c ST MARK S HOSPITAL   (United Kingdom)

Author keywords

HNPCC; Lynch syndrome; Mismatch repair immunohistochemistry

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; FEMALE; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; ONSET AGE; PATIENT REFERRAL; PRIORITY JOURNAL; UNITED KINGDOM;

ADENOCARCINOMA; ADULT; AGE OF ONSET; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENETIC COUNSELING; GENETIC TESTING; GREAT BRITAIN; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80051706634     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02685.x     Document Type: Article

References (21)

1. Vogelstein B, Kinzler KW. (2002) The Genetic Basis of Cancer. McGraw-Hill, Medical Pub Division, New York.
2. Dunlop MG, Farrington SM, Nicholl I et al. Population carrier frequency of hMSH2 and hMLH1 mutations. Br J Cancer 2000; 83: 1643-5.
3. Stupart DA, Goldberg PA, Baigrie RJ, Algar U, Ramesar R. Surgery for colonic cancer in HNPCC: total versus segmental colectomy. Colorectal Dis 2010; doi:.
4. Myrhoj T, Bisgaard ML, Bernstein I, Svendsen LB, Sondergaard JO, Bulow S. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol 1997; 32: 572-6.
5. de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 2002; 45: 1588-94.
6. Vasen HF, Möslein G, Alonso A et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007; 44: 353-62.
7. Jover R, Zapater P, Castells A et al. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer 2009; 45: 365-73.
8. Natarajan N, Watson P, Silva-Lopez E, Lynch HT. Comparison of extended colectomy and limited resection in patients with Lynch syndrome. Dis Colon Rectum 2010; 53: 77-82.
9. Lindor NM, Petersen GM, Hadley DW et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006; 296: 1507-17.
10. Limburg PJ, Harmsen WS, Chen HH et al. DNA Mismatch Repair Gene Alterations in a Population-Based Sample of Young-Onset Colorectal Cancer Patients. Clin Gastroenterol Hepatol 2011; 9: 497-502.
11. Aaltonen LA, Salovaara R, Kristo P et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-7.
12. Vasen HF, Moslein G, Alonso A et al. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 2010; 9: 109-15.
13. Ramsey SD, Burke W, Clarke L. An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer. Genet Med 2003; 5: 353-63.
14. Salovaara R, Loukola A, Kristo P et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 2000; 18: 2193-200.
15. Palmirotta R, Matera S, Curia MC et al. Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing. Fam Cancer 2004; 3: 117-21.
16. Jensen LH, Lindebjerg J, Byriel L, Kolvraa S, Cruger DG. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency. Colorectal Dis 2008; 10: 490-7.
17. Goel A, Nagasaka T, Spiegel J, Meyer R, Lichliter WE, Boland CR. Low frequency of Lynch syndrome among young patients with non-familial colorectal cancer. Clin Gastroenterol Hepatol 2010; 8: 966-71.
18. Umar A, Boland CR, Terdiman JP et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-8.
19. Trano G, Sjursen W, Wasmuth HH, Hofsli E, Vatten LJ. Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study. Br J Cancer 2010; 102: 482-8.
20. Foo W, Young JM, Solomon MJ, Wright CM. Family history? The forgotten question in high-risk colorectal cancer patients. Colorectal Dis 2009; 11: 450-5.
21. Trano G, Wasmuth HH, Sjursen W, Hofsli E, Vatten LJ. Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population-based study. Colorectal Dis 2009; 11: 456-61.